We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NEW YORK, Dec. 21 /PRNewswire-FirstCall/ -- XShares Advisors LLC announced today the distribution declarations for its family of five TDX Independence Exchange-Traded Funds (ETFs). For all...
Tyrian Diagnostics Limited (ASX:TDX) announced today that Tyrian and BD (Becton, Dickinson and Company) will not continue their collaboration to develop a Point-of-Care (PoC...
Tyrian Diagnostics Limited (ASX:TDX) announced today that it has completed manufacture and delivery of an initial order of ReadRite® ImmunoScanners to Bayer CropScience AG...
NEW YORK, July 31 /PRNewswire/ -- XShares Advisors LLC, a registered investment advisor, today announced that new advisory agreements had been adopted by the Board of Directors for the Funds. A...
Tyrian Diagnostics Limited (ASX:TDX) announced today that the company has completed the manufacture of an initial order of commercial ReadRite? alpha-amylase kits for Bayer...
Tyrian Diagnostics Limited (ASX:TDX) announced today that Tyrian and BD (Becton, Dickinson and Company) have entered an extended option period under their current agreement. The...
Tyrian Diagnostics Limited (ASX:TDX) announced today that the Company has completed Milestone 4 of a feasibility study in collaboration with Becton, Dickinson and Company (BD...
Tyrian Diagnostics Limited (ASX:TDX) announced today that the Company has agreed to commence the development of a second point-of-need diagnostic product with Bayer CropScience...
Tyrian Diagnostics Limited (ASX:TDX) announced today the appointment of new board member, Dr Merilyn Sleigh and the resignation of John Martin. Dr. Sleigh joins Tyrian with...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions